Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10029)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2014 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Minami Y, Nishida N, Kudo M. Therapeutic response assessment of RFA for HCC: Contrast-enhanced US, CT and MRI. World J Gastroenterol 2014; 20(15): 4160-4166 [PMID: 24764654 DOI: 10.3748/wjg.v20.i15.4160] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i15/4160.htm |
| Number | Citing Articles |
| 1 |
Shuhei NISHIGORI, Kazushi NUMATA, Kuniyasu IRIE, Hiroyuki FUKUDA, Makoto CHUMA, Shin MAEDA. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography. Choonpa Igaku 2020; 47(2): 81 doi: 10.3179/jjmu.JJMU.K.19
|
| 2 |
Hsin-Chih Huang, L. B. Gatchalian, Yi-Chung Hsieh, Wei-Ting Chen, Chen-Chun Lin, Shi-Ming Lin. Real-time virtual sonography-assisted radiofrequency ablation in liver tumors with conspicuous or inconspicuous images or peritumoral landmarks under ultrasonography. Abdominal Radiology 2021; 46(6): 2814 doi: 10.1007/s00261-020-02875-y
|
| 3 |
Emre Besler, Yearnchee Curtis Wang, Terence Chan, Alan Varteres Sahakian. Artificial Intelligence in Medicine. Lecture Notes in Computer Science 2019; 11526: 205 doi: 10.1007/978-3-030-21642-9_26
|
| 4 |
Qiannan Huang, Qingjing Zeng, Yinglin Long, Lei Tan, Rongqin Zheng, Erjiao Xu, Kai Li. Fusion imaging techniques and contrast-enhanced ultrasound for thermal ablation of hepatocellular carcinoma – A prospective randomized controlled trial. International Journal of Hyperthermia 2019; 36(1): 1206 doi: 10.1080/02656736.2019.1687945
|
| 5 |
Selena Y. Lin, Dina Halegoua-DeMarzio, Peter Block, Yu-Lan Kao, Jesse Civan, Fwu-Shan Shieh, Wei Song, Hie-Won Hann, Ying-Hsiu Su. Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study. Diagnostics 2023; 13(9): 1537 doi: 10.3390/diagnostics13091537
|
| 6 |
Erjiao Xu, Yinglin Long, Kai Li, Qingjing Zeng, Lei Tan, Liping Luo, Qiannan Huang, Rongqin Zheng. Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors. International Journal of Hyperthermia 2018; 35(1): 159 doi: 10.1080/02656736.2018.1487591
|
| 7 |
Guodong Wu, Jing Li, Changfeng Li, Xia Ou, Kai Feng, Feng Xia, Zhiyu Chen, Leida Zhang, Kuansheng Ma. Long‐term efficacy of no‐touch radiofrequency ablation in the treatment of single small hepatocellular carcinoma: A single center long‐term follow‐up study. Cancer Medicine 2023; 12(6): 6571 doi: 10.1002/cam4.5428
|
| 8 |
Ke Zhang, Li Jiang, Zhe Jia, Yao Zhang, Rong He, Zhenhao Ding, Yi Mu. Radiofrequency Ablation Plus Devascularization Is the Preferred Treatment of Hepatocellular Carcinoma with Esophageal Varices. Digestive Diseases and Sciences 2015; 60(5): 1490 doi: 10.1007/s10620-014-3455-1
|
| 9 |
Jian-Xiang Niu, Xing-Kai Meng, Jian-Jun Ren. Studied microRNA gene expression in human hepatocellular carcinoma by microRNA microarray techniques. World Journal of Gastroenterology 2015; 21(44): 12605-12611 doi: 10.3748/wjg.v21.i44.12605
|
| 10 |
Tomohiro Minami, Yasunori Minami, Hirokazu Chishina, Tadaaki Arizumi, Masahiro Takita, Satoshi Kitai, Norihisa Yada, Tatsuo Inoue, Satoru Hagiwara, Kazuomi Ueshima, Naoshi Nishida, Masatoshi Kudo. Combination Guidance of Contrast-Enhanced US and Fusion Imaging in Radiofrequency Ablation for Hepatocellular Carcinoma with Poor Conspicuity on Contrast-Enhanced US/Fusion Imaging. Oncology 2014; 87(Suppl. 1): 55 doi: 10.1159/000368146
|
| 11 |
Toru Beppu, Shigeki Nakagawa, Hidetoshi Nitta, Hirohisa Okabe, Takayoshi Kaida, Katsunori Imai, Hiromitsu Hayashi, Yuki Koga, Kunitaka Kuramoto, Daisuke Hashimoto, Yo-ichi Yamashita, Akira Chikamoto, Takatoshi Ishiko, Hideo Baba. The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2016.00055
|
| 12 |
Shilun Wu, Zhuxin Li, Changyu Yao, Shuying Dong, Jun Gao, Shan Ke, Ruhang Zhu, Sen Huang, Shaohong Wang, Li Xu, Chen Ye, Jian Kong, Wenbing Sun. Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1032746
|
| 13 |
Robbert S. Puijk, Alette H. Ruarus, Hester J. Scheffer, Laurien G.P.H. Vroomen, Aukje A.J.M. van Tilborg, Jan J.J. de Vries, Ferco H. Berger, Petrousjka M.P. van den Tol, Martijn R. Meijerink. Percutaneous Liver Tumour Ablation: Image Guidance, Endpoint Assessment, and Quality Control. Canadian Association of Radiologists Journal 2018; 69(1): 51 doi: 10.1016/j.carj.2017.11.001
|
| 14 |
A. Darnell, E. Belmonte, M. Reig, C. Brú. Evaluación postratamiento locorregional y sistémico del carcinoma hepatocelular. Radiología 2018; 60(5): 424 doi: 10.1016/j.rx.2018.05.004
|
| 15 |
Yasunori Minami, Masahiro Morita, Hirokazu Chishina, Tomoko Aoki, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Naoshi Nishida, Masatoshi Kudo. Can the Entire Ablative Hyperechoic Zone be Regarded as a Necrotic Lesion After Radiofrequency Ablation of the Liver?. Ultrasound in Medicine & Biology 2021; 47(10): 2930 doi: 10.1016/j.ultrasmedbio.2021.05.004
|
| 16 |
Xiao W Bo, Xiao L Li, Hui X Xu, Le H Guo, Dan D Li, Bo J Liu, Dan Wang, Ya P He, Xiao H Xu. 2D shear-wave ultrasound elastography (SWE) evaluation of ablation zone following radiofrequency ablation of liver lesions: is it more accurate?. The British Journal of Radiology 2016; 89(1060): 20150852 doi: 10.1259/bjr.20150852
|
| 17 |
Yasunori Minami, Tomohiro Minami, Hirokazu Chishina, Masashi Kono, Tadaaki Arizumi, Masahiro Takita, Norihisa Yada, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Naoshi Nishida, Masatoshi Kudo. US-US Fusion Imaging in Radiofrequency Ablation for Liver Metastases. Digestive Diseases 2016; 34(6): 687 doi: 10.1159/000448857
|
| 18 |
Dan Zhang, Hua-Ling Zhou, Chao-Lang Tang. Evaluation of short-term efficacy of radiofrequency ablation for hepatocellular carcinoma by dynamic three-dimensional contrast-enhanced ultrasound. World Chinese Journal of Digestology 2019; 27(8): 530 doi: 10.11569/wcjd.v27.i8.530
|
| 19 |
Feilong Ye, Lulu Xie, Licong Liang, Zhimei Zhou, Siqin He, Rui Li, Liteng Lin, Kangshun Zhu. Mechanisms and therapeutic strategies to combat the recurrence and progression of hepatocellular carcinoma after thermal ablation. Journal of Interventional Medicine 2023; 6(4): 160 doi: 10.1016/j.jimed.2023.10.004
|
| 20 |
Sang-Hoon Kim, Ki-Hun Kim, Byeong-Gon Na, Sung Min Kim, Rak-Kyun Oh. Primary treatments for solitary hepatocellular carcinoma ≤ 3 cm: A systematic review and network meta-analysis. Annals of Hepato-Biliary-Pancreatic Surgery 2024; 28(4): 397 doi: 10.14701/ahbps.24-103
|
| 21 |
Ji-ming Yin, Li-bo Sun, Jia-sheng Zheng, Xin-xin Wang, De-xi Chen, Ning Li. Copper chelation by trientine dihydrochloride inhibits liver RFA-induced inflammatory responses in vivo. Inflammation Research 2016; 65(12): 1009 doi: 10.1007/s00011-016-0986-2
|
| 22 |
Maxime Barat, Audrey Fohlen, Christophe Cassinotto, Anne Sophie Jannot, Raphael Dautry, Jean‐Pierre Pelage, Mourad Boudiaf, Marc Pocard, Clarisse Eveno, Bachir Taouli, Philippe Soyer, Anthony Dohan. One‐month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma. Journal of Magnetic Resonance Imaging 2017; 45(6): 1648 doi: 10.1002/jmri.25521
|
| 23 |
Fereshteh Yazdanpanah, Omar Al-Daoud, Moein Moradpour, Stephen Hunt. Measures for response assessment in HCC treatment. Hepatoma Research 2024; doi: 10.20517/2394-5079.2024.60
|
| 24 |
Sung Mo Kim, Sang Soo Shin, Byung Chan Lee, Jin Woong Kim, Suk Hee Heo, Chung Hwan Jun, Yong Yeon Jeong. Assessment of Treatment Efficacy Immediately After Combined Therapy of Ultrasound-Guided Radiofrequency Ablation and Conventional Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Comparison Between Multidetector-Row CT and MRI. Iranian Journal of Radiology 2019; (In Press) doi: 10.5812/iranjradiol.80926
|
| 25 |
Jin-Xiu Ju, Qing-Jing Zeng, Er-Jiao Xu, Xu-Qi He, Lei Tan, Qian-Nan Huang, Kai Li, Rong-Qin Zheng. Intraprocedural contrast-enhanced ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation to reduce local tumor progression: compared with routine contrast-enhanced ultrasound. International Journal of Hyperthermia 2019; 36(1): 784 doi: 10.1080/02656736.2019.1640899
|
| 26 |
Fenghai Liu, Baozhou Hou, Zhuofu Li, Lei Zhang, Yingwen Zhou, Hao Bian, Zhaoyang Huo. Microwave ablation of multifocal primary liver cancer guided by real-time 3.0T MRI. International Journal of Hyperthermia 2023; 40(1) doi: 10.1080/02656736.2023.2228519
|
| 27 |
Mohammed Mostafa Sayed Mostafa. Diffusion weighted and dynamic contrast enhanced magnetic resonance imaging in assessment of malignant liver tumors after percutaneous radiofrequency ablation. The Egyptian Journal of Radiology and Nuclear Medicine 2016; 47(4): 1195 doi: 10.1016/j.ejrnm.2016.08.017
|
| 28 |
Nobuyuki Takeyama, Naruki Mizobuchi, Masashi Sakaki, Yu Shimozuma, Jiro Munechika, Atsushi Kajiwara, Manabu Uchikoshi, Syojiro Uozumi, Yoshimitsu Ohgiya, Takehiko Gokan. Evaluation of hepatocellular carcinoma ablative margins using fused pre- and post-ablation hepatobiliary phase images. Abdominal Radiology 2019; 44(3): 923 doi: 10.1007/s00261-018-1800-0
|
| 29 |
Masaki Ueno, Takuya Nakai, Michihiro Hayashi, Fumitoshi Hirokawa, Hiroaki Nagano, Hiroshi Wada, Masaki Kaibori, Kosuke Matsui, Shogo Tanaka, Hiroki Yamaue, Shoji Kubo. Survival outcome of salvage hepatectomy in patients with local, recurrent hepatocellular carcinoma who underwent radiofrequency ablation as their first treatment. Surgery 2016; 160(3): 661 doi: 10.1016/j.surg.2016.04.023
|
| 30 |
Liat Mlynarsky, Yoram Menachem, Oren Shibolet. Treatment of hepatocellular carcinoma: Steps forward but still a long way to go. World Journal of Hepatology 2015; 7(3): 566-574 doi: 10.4254/wjh.v7.i3.566
|
| 31 |
Herman P. Marquez, Gilbert Puippe, Rishi Philip Mathew, Hatem Alkadhi, Thomas Pfammatter, Michael A. Fischer. CT Perfusion for Early Response Evaluation of Radiofrequency Ablation of Focal Liver Lesions: First Experience. CardioVascular and Interventional Radiology 2017; 40(1): 90 doi: 10.1007/s00270-016-1444-9
|
| 32 |
Sanjay Bansal, Jonathan Gui, Christina Merrill, Jason K. Wong, Kelly W. Burak, Stephanie R. Wilson. Contrast-enhanced US in Local Ablative Therapy and Secondary Surveillance for Hepatocellular Carcinoma. RadioGraphics 2019; 39(5): 1302 doi: 10.1148/rg.2019180205
|
| 33 |
Hidetoshi Nitta, Shigeki Nakagawa, Takayoshi Kaida, Kota Arima, Takaaki Higashi, Katsunobu Taki, Hirohisa Okabe, Hiromitsu Hayashi, Daisuke Hashimoto, Akira Chikamoto, Takatoshi Ishiko, Toru Beppu, Hideo Baba. Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma. Surgery Today 2017; 47(3): 375 doi: 10.1007/s00595-016-1385-6
|
| 34 |
Minoru Tomizawa, Fuminobu Shinozaki, Kazunori Fugo, Satomi Tanaka, Takafumi Sunaoshi, Daisuke Kano, Eriko Sugiyama, Misaki Shite, Ryouta Haga, Yoshiya Fukamizu, Toshiyuki Fujita, Satoshi Kagayama, Rumiko Hasegawa, Akira Togawa, Yoshinori Shirai, Noboru Ichiki, Yuji Oshima, Naoto Koike, Yasuko Toshimitsu, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto, Takashi Kishimoto, Naoki Ishige. Diagnostic accuracy of diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion for the detection of abdominal solid cancer. Experimental and Therapeutic Medicine 2017; 13(6): 3509 doi: 10.3892/etm.2017.4432
|
| 35 |
Ruiqing Liu, Shaobo Duan, Huicun Cao, Guangshao Cao, Zhiyang Chang, Ye Zhang, Yaqiong Li, Yuejin Wu, Luwen Liu, Lianzhong Zhang, Peter F.W.M. Rosier. A pilot study of the shapes of ablation lesions in the canine prostate by laser, radiofrequency and microwave and their clinical significance. PLOS ONE 2020; 15(4): e0223229 doi: 10.1371/journal.pone.0223229
|
| 36 |
Yazhao Li, Haoyu Wang, Danfeng Ren, Jingyu Li, Zihan Mu, Chaoyi Li, Yongchao He, Jiayi Zhang, Rui Fan, Jiayuan Yin, Jiaojiao Su, Yinli He, Bowen Yao. Interleukin-41: a novel serum marker for the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1408584
|
| 37 |
Yasunori Minami, Tomohiro Minami, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Naoshi Nishida, Masatoshi Kudo. Radiofrequency ablation for hepatocellular carcinoma: Clinical value of ultrasound–ultrasound overlay fusion for optimal ablation and local controllability. Hepatology Research 2020; 50(1): 67 doi: 10.1111/hepr.13407
|
| 38 |
Yasunori Minami, Tomohiro Minami, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Naoshi Nishida, Takamichi Murakami, Masatoshi Kudo. Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma. European Radiology 2018; 28(5): 1986 doi: 10.1007/s00330-017-5162-8
|
| 39 |
Shuhei Nishigori, Kazushi Numata, Kuniyasu Irie, Hiroyuki Fukuda, Makoto Chuma, Shin Maeda. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography. Journal of Medical Ultrasonics 2018; 45(3): 405 doi: 10.1007/s10396-018-0861-6
|
| 40 |
Devin C. Flaherty, Anton J. Bilchik. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 1436 doi: 10.1016/B978-0-323-34062-5.00126-6
|
| 41 |
Toshikazu Ito, Hironobu Manabe, Michiyo Kubota, Yoshifumi Komoike. Current status and future perspectives of contrast-enhanced ultrasound diagnosis of breast lesions. Journal of Medical Ultrasonics 2024; 51(4): 611 doi: 10.1007/s10396-024-01486-0
|
| 42 |
Mengjiao Xu, Liu Yang, Yanjie Lin, Yao Lu, Xiaoyue Bi, Tingting Jiang, Wen Deng, Lu Zhang, Wei Yi, Yao Xie, Minghui Li. Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01615-2
|
| 43 |
Agostino Inzerillo, Maria Franca Meloni, Adele Taibbi, Tommaso Vincenzo Bartolotta. Loco-regional treatment of hepatocellular carcinoma: Role of contrast-enhanced ultrasonography. World Journal of Hepatology 2022; 14(5): 911-922 doi: 10.4254/wjh.v14.i5.911
|
| 44 |
Massimo Venturini, Claudio Sallemi. Benign Tumors of the Liver. 2015; : 281 doi: 10.1007/978-3-319-12985-3_21
|
| 45 |
Yoshiteru Hao, Kazushi Numata, Tomohiro Ishii, Hiroyuki Fukuda, Shin Maeda, Masayuki Nakano, Katsuaki Tanaka. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(17): 3111-3121 doi: 10.3748/wjg.v23.i17.3111
|
| 46 |
Parag Amin, Joseph Ness, McKenzie Brown, Ian Sullivan. Deciphering Liver Imaging After Interventional Oncology Treatments for Hepatocellular Carcinoma. Contemporary Diagnostic Radiology 2021; 44(7): 1 doi: 10.1097/01.CDR.0000737148.84800.7d
|
| 47 |
Mohamed Amin Nassef. Added value of diffusion weighted MRI in evaluation of treatment response: post radiofrequency ablation for hepatocellular carcinoma. The Egyptian Journal of Radiology and Nuclear Medicine 2015; 46(3): 581 doi: 10.1016/j.ejrnm.2015.05.010
|
| 48 |
Marco Gatti, Cesare Maino, Fatemeh Darvizeh, Alessandro Serafini, Eleonora Tricarico, Alessia Guarneri, Riccardo Inchingolo, Davide Ippolito, Umberto Ricardi, Paolo Fonio, Riccardo Faletti. Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment. World Journal of Gastroenterology 2022; 28(26): 3116-3131 doi: 10.3748/wjg.v28.i26.3116
|
| 49 |
Ying-Hsiu Su, Amy K. Kim, Surbhi Jain. Liquid biopsies for hepatocellular carcinoma. Translational Research 2018; 201: 84 doi: 10.1016/j.trsl.2018.07.001
|
| 50 |
Jinshun Xu, Yu Chen, Liming Deng, Jianxin Liu, Yang Cao, Pan Li, Haitao Ran, Yuanyi Zheng, Zhigang Wang. Microwave-activated nanodroplet vaporization for highly efficient tumor ablation with real-time monitoring performance. Biomaterials 2016; 106: 264 doi: 10.1016/j.biomaterials.2016.08.034
|
| 51 |
Jei‐Ming Peng, Rabindranath Bera, Chih‐Yung Chiou, Ming‐Chin Yu, Tse‐Chin Chen, Chia‐Wei Chen, Tsung‐Rui Wang, Wan‐Ling Chiang, Shin‐Pei Chai, Yongkun Wei, Huamin Wang, Mien‐Chie Hung, Sen‐Yung Hsieh. Actin cytoskeleton remodeling drives epithelial‐mesenchymal transition for hepatoma invasion and metastasis in mice. Hepatology 2018; 67(6): 2226 doi: 10.1002/hep.29678
|
| 52 |
Qian Yu, Chenyu Liu, Rakesh Navuluri, Osman Ahmed. Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Abdominal Radiology 2021; 46(9): 4467 doi: 10.1007/s00261-021-03080-1
|
| 53 |
Xuefeng Kan, Guanhui Zhou, Feng Zhang, Hongxiu Ji, Hui Zheng, Jeffrey Forris Beecham Chick, Karim Valji, Chuansheng Zheng, Xiaoming Yang. Interventional Optical Imaging Permits Instant Visualization of Pathological Zones of Ablated Tumor Periphery and Residual Tumor Detection. Cancer Research 2021; 81(17): 4594 doi: 10.1158/0008-5472.CAN-21-1040
|
| 54 |
Diana Gabriela Domínguez-Lazcano. Alpha-fetoprotein, glypican-3, and kininogen-1 as biomarkers for the diagnosis of hepatocellular carcinoma. International Journal of Clinical and Experimental Pathology 2024; 17(11): 383 doi: 10.62347/QSII4050
|
| 55 |
Rony Kampalath, Karen Tran-Harding, Richard K.G. Do, Mishal Mendiratta-Lala, Vahid Yaghmai. Evaluation of Hepatocellular Carcinoma Treatment Response After Locoregional Therapy. Magnetic Resonance Imaging Clinics of North America 2021; 29(3): 389 doi: 10.1016/j.mric.2021.05.013
|
| 56 |
Hsin-You Ou, Yu-Fan Cheng, Yi-Hsuan Chuang, Hsien-Wen Hsu, Chao-Long Chen, Marirose Zingapan Lazo, Ching-Chun Weng, Chun-Yen Yu, Leo Leung-Chit Tsang, Tung-Liang Huang, Yu-Shun Tong. Quantification of Functional MR Predicts Early Response in Post-doxorubicin Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma. Digestive Diseases and Sciences 2020; 65(8): 2433 doi: 10.1007/s10620-019-05951-6
|
| 57 |
Maria Franca Meloni, Giampiero Francica, Jason Chiang, Andrea Coltorti, Roberta Danzi, Paul F. Laeseke. Use of Contrast‐Enhanced Ultrasound in Ablation Therapy of HCC. Journal of Ultrasound in Medicine 2021; 40(5): 879 doi: 10.1002/jum.15471
|
| 58 |
Yunpeng Kong, Yan Jing, Hongmei Sun, Shisheng Zhou, Bhagyaveni M.A. The Diagnostic Value of Contrast-Enhanced Ultrasound and Enhanced CT Combined with Tumor Markers AFP and CA199 in Liver Cancer. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/5074571
|